AbCellera Q1 2026 Results — Positive Phase 1 Data for ABCL635

Definition

$ABCL (AbCellera Biologics Inc.) reports Q1 2026 business results alongside positive interim Phase 1 clinical data for ABCL635.

Sources

• raw/Stocks/2026-05-11-abcellerabio-abcellera-q1-results-positive-phase-abcl635.md